Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew White

Showing results (331-340 of 357) with videos related to

Pageof 36
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 13, 2022
Are Non-animal Systemic Safety Assessments Protective? A Toolbox and WorkflowAlistair M Middleton, Joe Reynolds, Sophie Cable, et al.
ALTEX|May 8, 2012
A toxicology ontology roadmapBarry Hardy, Gordana Apic, Philip Carthew, et al.
ALTEX|May 8, 2012
Toxicology ontology perspectivesBarry Hardy, Gordana Apic, Philip Carthew, et al.
Research Square|May 15, 2024
Opportunities for targeted therapies: trametinib as a therapeutic approach to canine oral squamous cell carcinomasSantiago Peralta, William Katt, Cheryl Balkman, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2017
CD1b-restricted GEM T cell responses are modulated by <i>Mycobacterium tuberculosis</i> mycolic acid meromycolate chainsAndrew Chancellor, Anna S Tocheva, Chris Cave-Ayland, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 11, 2020
A Next-Generation Risk Assessment Case Study for Coumarin in Cosmetic ProductsMaria T Baltazar, Sophie Cable, Paul L Carmichael, et al.
Environmental Health Perspectives|May 9, 2015
Chemical Safety Assessment Using Read-Across: Assessing the Use of Novel Testing Methods to Strengthen the Evidence Base for Decision MakingElisabet Berggren, Patric Amcoff, Romualdo Benigni, et al.
Journal for Immunotherapy of Cancer|July 9, 2025
Gene-expression signature predicts autoimmune toxicity in metastatic melanomaDomenico Mallardo, Mario Fordellone, Michael Bailey, et al.
Journal for Immunotherapy of Cancer|November 24, 2022
Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysisDomenico Mallardo, Diana Giannarelli, Maria Grazia Vitale, et al.
The British Journal of Ophthalmology|September 7, 2019
Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trialGhee Soon Ang, Eva K Fenwick, Marios Constantinou, et al.
Pageof 36

Showing results (331-340 of 357) with videos related to

Sort By:
Pageof 36
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 13, 2022
Are Non-animal Systemic Safety Assessments Protective? A Toolbox and WorkflowAlistair M Middleton, Joe Reynolds, Sophie Cable, et al.
ALTEX|May 8, 2012
A toxicology ontology roadmapBarry Hardy, Gordana Apic, Philip Carthew, et al.
ALTEX|May 8, 2012
Toxicology ontology perspectivesBarry Hardy, Gordana Apic, Philip Carthew, et al.
Research Square|May 15, 2024
Opportunities for targeted therapies: trametinib as a therapeutic approach to canine oral squamous cell carcinomasSantiago Peralta, William Katt, Cheryl Balkman, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2017
CD1b-restricted GEM T cell responses are modulated by <i>Mycobacterium tuberculosis</i> mycolic acid meromycolate chainsAndrew Chancellor, Anna S Tocheva, Chris Cave-Ayland, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 11, 2020
A Next-Generation Risk Assessment Case Study for Coumarin in Cosmetic ProductsMaria T Baltazar, Sophie Cable, Paul L Carmichael, et al.
Environmental Health Perspectives|May 9, 2015
Chemical Safety Assessment Using Read-Across: Assessing the Use of Novel Testing Methods to Strengthen the Evidence Base for Decision MakingElisabet Berggren, Patric Amcoff, Romualdo Benigni, et al.
Journal for Immunotherapy of Cancer|July 9, 2025
Gene-expression signature predicts autoimmune toxicity in metastatic melanomaDomenico Mallardo, Mario Fordellone, Michael Bailey, et al.
Journal for Immunotherapy of Cancer|November 24, 2022
Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysisDomenico Mallardo, Diana Giannarelli, Maria Grazia Vitale, et al.
The British Journal of Ophthalmology|September 7, 2019
Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trialGhee Soon Ang, Eva K Fenwick, Marios Constantinou, et al.
Pageof 36